Items where authors include "Mummery, C.J."

Article

Mummery, C.J. orcid.org/0000-0002-6739-0803, Rasmussen, J. orcid.org/0000-0003-4365-0428, Blackburn, D. orcid.org/0000-0001-8886-1283 et al. (20 more authors) (2025) Lecanemab appropriate use recommendations for clinical practice in the UK. Journal of Neurology, Neurosurgery & Psychiatry. jnnp-2025. ISSN 0022-3050

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Mummery, C.J. orcid.org/0000-0002-6739-0803, Börjesson-Hanson, A., Blackburn, D.J. et al. (24 more authors) (2023) Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial. Nature Medicine, 29. pp. 1437-1447. ISSN 1078-8956

Proceedings Paper

Cohen, S., Ducharme, S., Brosch, J.R. et al. (9 more authors) (2025) Multiple‐dose results from an ongoing phase 1 study of mivelsiran, an investigational RNA interference therapeutic targeting amyloid‐beta precursor protein for Alzheimer’s disease. In: Alzheimer's & Dementia. Alzheimer's Association International Conference 2025 (AAIC 2025), 27-31 Jul 2025, Toronto, Canada. Wiley .